Trinity Biotech Promotes John Gillard to CEO Role; Aris Kekedjian Resigns
By Sabela Ojea Trinity Biotech promoted finance chief John Gillard as its new president and chief executive, as Aris Kekedjian has resigned. The developer...
Stay updated with breaking news from Trinity Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Sabela Ojea Trinity Biotech promoted finance chief John Gillard as its new president and chief executive, as Aris Kekedjian has resigned. The developer...
DUBLIN--(BUSINESS WIRE)--The "Global Hemoglobin A1C Testing Market, Forecast to 2028" report has been added to ResearchAndMarkets.com's offering.The global hemoglobin A1C (HbA1c) testing market will witness significant growth driven by technological advances and the increasing adoption of point-of-care testing (POCT...
StockNews.com began coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research report sent to investors on Sunday morning. The firm issued a buy rating on the stock. Trinity Biotech Price Performance Shares of NASDAQ TRIB opened at $0.50 on Friday. Trinity Biotech has a one year low of $0.37 and a […]
StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a buy rating on the stock. Trinity Biotech Price Performance Shares of TRIB stock opened at $0.49 on Friday. The company has a market cap of $18.67 million, a price-to-earnings […]
StockNews.com assumed coverage on shares of Trinity Biotech (NASDAQ:TRIB – Free Report) in a report published on Sunday morning. The firm issued a buy rating on the stock. Trinity Biotech Price Performance Trinity Biotech stock opened at $0.49 on Friday. Trinity Biotech has a 1-year low of $0.37 and a 1-year high of $1.29. The […]